Advertisement
Advertisement
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:11PM EDT. Market open.
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 71.61 |
| Open | 71.15 |
| Bid | 69.64 x 900 |
| Ask | 69.72 x 900 |
| Day's Range | 69.21 - 71.26 |
| 52 Week Range | 61.28 - 101.24 |
| Volume | |
| Avg. Volume | 770,729 |
| Market Cap | 6.114B |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.28 |
| Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 118.33 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Subscribe to Yahoo Finance Plus to view Fair Value for SRPT
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Sarepta Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 11/30/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat6 months agoArgus Research
- American City Business Journals
Ohio gene therapy industry gets 'buzz' – but needs to sell itself more
Cell and gene therapy researchers and companies in Ohio attract buzz, but a panel of experts said the industry needs to do better at promoting a statewide brand to attract talent.
- Zacks
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1
Bayer (BAYRY) beats estimates for both earnings and revenues in the first quarter of 2022.
- Simply Wall St.
Bullish insiders bet US$2.3m on Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Quite a few insiders have dramatically grown their holdings in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) over the past...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
